Works from 2025
Timing for Assessment of Bleeding Diathesis in Pediatric Blunt Traumatic Brain Injury., Kasey Chelemedos, Stephanie Papillon, Sahal Master, Harsh Grewal, and Nataly Apollonsky(Article)
Works from 2024
Successful Crizotinib-targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma., Megan L Wood, Julie C Fanburg-Smith, James M Brian, Jason C White, Jonathan L Powell, and Andrew S Freiberg(Article)
Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational>Trial., Gary M Woods, Alexandra Miller, Maua Mosha, Christoph Male, Anupam Verma, Nicole Kucine, Christine Sabapathy, Kisha Beg, Sanjay Ahuja, Deepti Raybagkar, Kerry Hege, Clara Lo, Rukhmi Bhat, Thomas Abshire, and Neil A Goldenberg(Article)
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells., Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai-Kong V Cheung, and Lawrence G Lum(Article)